EU adopts tougher safeguards on genetic modification
نویسندگان
چکیده
منابع مشابه
Multilayered genetic safeguards limit growth of microorganisms to defined environments
Genetically modified organisms (GMOs) are commonly used to produce valuable compounds in closed industrial systems. However, their emerging applications in open clinical or environmental settings require enhanced safety and security measures. Intrinsic biocontainment, the creation of bacterial hosts unable to survive in natural environments, remains a major unsolved biosafety problem. We develo...
متن کاملSmaller is tougher
Smaller is tougher A.R. Beaber a , J.D. Nowak b , O. Ugurlu c , W.M. Mook d , S.L. Girshick e , R. Ballarini f & W.W. Gerberich a a Department of Chemical Engineering and Materials Science, University of Minnesota, 421 Washington Ave SE, Minneapolis, MN 55455, USA b Hysitron Incorporated, 10025 Valley View Road, Minneapolis, Minnesota 55344, USA c Characterization Facility, University of Minnes...
متن کاملGenetic modification and genetic determinism
In this article we examine four objections to the genetic modification of human beings: the freedom argument, the giftedness argument, the authenticity argument, and the uniqueness argument. We then demonstrate that each of these arguments against genetic modification assumes a strong version of genetic determinism. Since these strong deterministic assumptions are false, the arguments against g...
متن کاملIntroduction to Genetic Modification
Genetic modification of plants and animals by sexual crossing has been taking place for thousands of years. It began when humans decided to stay in one place rather than move from place to place in search of food. To increase the amount of food available they chose plants or animals with improved characteristics to breed, or “cross,” for the next generation. For example, they might have crossed...
متن کاملGenetic Modification of T Cells
Gene transfer technology has advanced rapidly from simple physical-chemical laboratory methods in the 1970s and 1980s to the sophisticated viral and nonviral methods currently in clinical practice. Herein, we review 4 gene transfer methodologies applied in human gene therapy clinical trials transferring chimeric antigen receptors into T cells for the treatment of B-cell malignancies. The 4 meth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1999
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.319.7201.11a